ResMed Inc. RMD | NYSE
Company Overview:
10 Year Performance Metrics:
RMD Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
RMD Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
RMD Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
RMD Dividends Info:
RMD Dividend History: Dates, Payments & Yield list
Below is a schedule of all RMD dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
| Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 05/08/2025 | 06/12/2025 | $0.530 | 0.9% | 0.9% | $236.49 |
| 02/13/2025 | 03/20/2025 | $0.530 | 0.86% | 0.89% | $239.48 |
| 11/07/2024 | 12/12/2024 | $0.530 | 0.81% | 0.85% | $248.54 |
| 08/15/2024 | 09/19/2024 | $0.530 | 0.87% | 0.93% | $227.22 |
| 05/08/2024 | 06/13/2024 | $0.480 | 0.9% | 0.9% | $212.88 |
| 02/07/2024 | 03/14/2024 | $0.480 | 1.01% | 1.03% | $186.59 |
| 11/08/2023 | 12/14/2023 | $0.480 | 1.24% | 1.29% | $148.78 |
| 08/16/2023 | 09/21/2023 | $0.480 | 1.04% | 1.11% | $173.71 |
| 05/10/2023 | 06/15/2023 | $0.440 | 0.75% | 0.75% | $233.50 |
| 02/08/2023 | 03/16/2023 | $0.440 | 0.79% | 0.8% | $220.96 |
| 11/09/2022 | 12/15/2022 | $0.440 | 0.81% | 0.83% | $211.96 |
| 08/17/2022 | 09/22/2022 | $0.440 | 0.72% | 0.74% | $236.41 |
| 05/11/2022 | 06/16/2022 | $0.420 | 0.88% | 0.88% | $191.46 |
| 02/09/2022 | 03/17/2022 | $0.420 | 0.67% | 0.68% | $246.48 |
| 11/09/2021 | 12/16/2021 | $0.420 | 0.62% | 0.64% | $261.65 |
| 08/18/2021 | 09/23/2021 | $0.420 | 0.57% | 0.6% | $279.57 |
| 05/12/2021 | 06/17/2021 | $0.390 | 0.81% | 0.81% | $192.32 |
| 02/10/2021 | 03/18/2021 | $0.390 | 0.78% | 0.78% | $200.40 |
| 11/10/2020 | 12/17/2020 | $0.390 | 0.74% | 0.74% | $212.11 |
| 08/19/2020 | 09/24/2020 | $0.390 | 0.85% | 0.85% | $183.43 |
| 05/13/2020 | 06/18/2020 | $0.390 | 0.95% | 0.95% | $164.37 |
| 02/12/2020 | 03/19/2020 | $0.390 | 0.89% | 0.9% | $172.76 |
| 11/06/2019 | 12/12/2019 | $0.390 | 1.06% | 1.09% | $143.25 |
| 08/14/2019 | 09/19/2019 | $0.390 | 1.14% | 1.19% | $131.15 |
| 05/08/2019 | 06/13/2019 | $0.370 | 1.33% | 1.33% | $111.42 |
| 02/06/2019 | 03/14/2019 | $0.370 | 1.53% | 1.55% | $95.59 |
| 11/07/2018 | 12/13/2018 | $0.370 | 1.34% | 1.38% | $107.59 |
| 08/15/2018 | 09/20/2018 | $0.370 | 1.33% | 1.38% | $107.14 |
| 05/09/2018 | 06/14/2018 | $0.350 | 1.43% | 1.43% | $98.16 |
| 02/07/2018 | 03/15/2018 | $0.350 | 1.49% | 1.51% | $92.59 |
| 11/08/2017 | 12/14/2017 | $0.350 | 1.65% | 1.7% | $82.19 |
| 08/15/2017 | 09/21/2017 | $0.350 | 1.85% | 1.93% | $72.44 |
| 05/09/2017 | 06/15/2017 | $0.330 | 1.96% | 1.96% | $67.46 |
| 02/07/2017 | 03/16/2017 | $0.330 | 1.87% | 1.91% | $68.93 |
| 11/08/2016 | 12/15/2016 | $0.330 | 2.19% | 2.29% | $57.59 |
| 08/16/2016 | 09/22/2016 | $0.330 | 1.78% | 1.91% | $69.09 |
| 05/17/2016 | 06/16/2016 | $0.300 | 2.1% | 2.1% | $57.23 |
| 02/09/2016 | 03/17/2016 | $0.300 | 2.06% | 2.1% | $57.18 |
| 11/17/2015 | 12/17/2015 | $0.300 | 2.01% | 2.08% | $57.58 |
| 08/18/2015 | 09/17/2015 | $0.300 | 2.08% | 2.19% | $54.89 |
| 05/19/2015 | 06/18/2015 | $0.280 | 1.97% | 1.97% | $56.83 |
| 02/10/2015 | 03/19/2015 | $0.280 | 1.71% | 1.76% | $63.78 |
| 11/18/2014 | 12/18/2014 | $0.280 | 2.03% | 2.14% | $52.32 |
| 08/19/2014 | 09/18/2014 | $0.280 | 2% | 2.17% | $51.53 |
| 05/16/2014 | 06/17/2014 | $0.250 | 1.98% | 1.98% | $50.57 |
| 02/14/2014 | 03/19/2014 | $0.250 | 2.01% | 2.19% | $45.74 |
| 11/15/2013 | 12/18/2013 | $0.250 | 1.65% | 1.96% | $51.05 |
| 08/16/2013 | 09/17/2013 | $0.250 | 1.53% | 2.02% | $49.52 |
| 05/17/2013 | 06/18/2013 | $0.170 | 1.36% | 1.36% | $50.07 |
| 02/14/2013 | 03/19/2013 | $0.170 | 1.18% | 1.57% | $43.18 |
| 11/16/2012 | 12/18/2012 | $0.170 | 0.87% | 1.74% | $39.10 |
| 09/05/2012 | 09/28/2012 | $0.170 | 0.44% | 1.77% | $38.45 |
Projected Future Returns & Dividends for RMD
Based on past 10-year performance, here are RMD growth metrics:
Share price CAGR of +13.82%
Dividend CAGR of +6.6%
Using RMD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| RMD (DRIP) | RMD - No DRIP | |
|---|---|---|
| Current Price | $236.49 | $236.49 |
| Start Shares | 42.29 | 42.29 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 45.25 | 42.29 |
| Dividends Payment | $1.00 | $1.00 |
| Annual Dividends | $182 | $170 |
| Yield on cost | 1.82% | 1.70% |
| Share Price | $758.49 | $758.49 |
| Total Dividends | $1,266 | $1,215 |
| Final Value | $34,325 | $33,288 |
NOTE: Above numbers are our estimate based on RMD's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
ResMed Inc. (RMD) had its IPO on 1995-06-02, and is trader on NYSE stock exchange.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
RMD website: https://www.resmed.com
